If your child needs a stronger prescription year after year, you are not alone, and acting on it is exactly the right instinct. The faster a child's nearsightedness progresses, the higher their lifetime risk of serious eye problems like retinal detachment and glaucoma, which is why slowing it matters. Mudgil Eye Associates offers myopia control for Paoli families about 20 minutes away via Route 30 (Lancaster Avenue), with both MiSight contact lenses, which are FDA-approved to slow myopia progression, and low-dose atropine, guided by a Johns Hopkins fellowship-trained pediatric ophthalmologist and a residency-trained pediatric optometrist. We are a complete MD-and-OD team, so if anything beyond myopia ever comes up, expert care is already in place.
Paoli anchors the western Main Line, spread along Route 30 (Lancaster Avenue) around the busy Paoli rail station and the edge of the Great Valley, across Willistown, Tredyffrin, and East Whiteland townships. Families from Paoli, Malvern, Frazer, and the surrounding neighborhoods often make the roughly 20-minute drive down Route 30 to our West Chester office once a child's prescription starts climbing at every exam. Slowing that climb is precisely what a myopia control plan is meant to do.
Myopia control is less a product than an ongoing program, one we measure, adjust, and follow across several years of growth. Between screen-heavy classrooms, growing homework loads, and less time outdoors than earlier generations enjoyed, more Paoli children are becoming nearsighted at younger ages than their parents were. And because Mudgil Eye Associates brings together a residency-trained pediatric optometrist and a Johns Hopkins fellowship-trained pediatric ophthalmologist under one roof, whatever your child's eyes might need is already covered.
MiSight is an FDA-approved daily contact lens proven to slow the progression of myopia in children. Your child wears it during the day, and it both corrects vision and helps keep the prescription from climbing as quickly. We are listed on the manufacturer's official provider locator.
Dr. A. Vijay Mudgil completed his pediatric ophthalmology fellowship at the Wilmer Eye Institute, Johns Hopkins, and our optometrist provides residency-trained pediatric care. Your child's myopia plan is overseen by pediatric eye specialists who do this every day.
For children who are not ready for contact lenses, we also offer low-dose atropine eye drops, a simple nightly drop widely used to help slow myopia progression. We help you choose the approach that fits your child best, and some children do well with a combination.
We are a complete MD-and-OD practice. A fellowship-trained pediatric ophthalmologist works alongside our optometrist, so if your child ever needs more than myopia control, a pediatric ophthalmologist's expertise is already part of their care.
Nearsightedness is easy to picture as a blurry chalkboard solved by a new pair of glasses, but the real change is structural. In a myopic eye, the eyeball has grown slightly too long from front to back, a process called axial elongation. Since that extra length seats the retina too far back, distant light focuses just before reaching it, so far objects blur while near ones stay clear. Glasses and standard contacts bend the light back into focus, but they leave the eye's length, and its ongoing growth, untouched. Guiding that growth is the whole aim of myopia control.
What is at stake is much more than a thinner lens next year. Each additional degree of nearsightedness leaves a longer, more stretched eye and raises the lifetime odds of retinal detachment, glaucoma, cataract at a younger age, and myopic maculopathy in adulthood. By slowing how fast the myopia accumulates during the growing years, we aim to leave your child with a lower adult prescription, and a lower prescription means lower long-term risk. Just as importantly, myopia control does not cure or reverse the nearsightedness already there, and results vary from child to child, though for most children it slows the pace meaningfully.
Childhood myopia is climbing nationwide, and the Paoli area follows the same pattern. Family history counts for a great deal, so a child with nearsighted parents starts at higher risk, but the environment plays its part too. Long hours of near focus for schoolwork, reading, and screens, alongside fewer hours outside in daylight, line up with faster progression. For a Paoli family, protecting a regular block of outdoor time is one of the simplest evidence-supported steps available, which is why we build daily habits into the plan rather than leaving them aside.
Once a Paoli child is old enough and ready to manage a contact lens, MiSight 1 day is frequently our first recommendation. It is the only soft contact lens the FDA has approved specifically to slow myopia progression in children, and since it is a daily-disposable lens worn during the day, it also corrects distance vision while it is worn. Many families find that convenient at school and on the field, and results vary from child to child.
On the eye, a MiSight lens feels like an ordinary soft contact, but it is designed with concentric treatment zones. The central zone provides clear distance vision while the outer zones focus part of the light just ahead of the peripheral retina, a signal that appears to slow the eye's tendency to keep elongating. In the manufacturer's multi-year clinical study, children wearing MiSight progressed far more slowly on average than a control group, roughly a 59 percent reduction in the rate of progression over three years. That figure is a clinical-study result, and the benefit for any individual child will vary.
MiSight generally suits school-age and older children, commonly starting around ages 8 to 12, who are responsible enough to insert, remove, and care for a lens with a parent's help at first. Because a fresh lens is used each day and discarded at night, there is no solution or case to manage. Significant astigmatism can rule a child out, which Dr. Julakanti evaluates at the fitting. For the lenses to work, they need to be worn most of the day, generally ten or more hours a day, six or more days a week, until the eyes finish growing and the prescription stabilizes.
For a Paoli child who is not yet ready to handle a contact lens, a single drop at bedtime can be the simplest way into myopia control. Low-dose atropine has become one of the most talked-about approaches to slowing childhood nearsightedness, and for a well-chosen patient it is easy to use and well tolerated. Because it asks so little of the child, it is a frequent starting point for younger patients.
Atropine is a long-standing eye medicine. In the very dilute concentrations used for myopia control, typically 0.01% to 0.05%, it is prescribed off-label to slow the eye's lengthening over time. That is a different aim, at a far weaker strength, than the dilating drops used at a comprehensive eye exam, which is why the side effects people tend to associate with atropine stay minimal at these small doses.
The appeal is how little it disrupts. One drop goes into each eye at bedtime, folded into the usual nighttime routine, and the child wears their regular glasses through the day. Nothing has to be inserted, cleaned, or stored. Because the concentration is so low, many children feel nothing at all, while a few mention slight light sensitivity or a small change in near focus, which we watch for and can ease by adjusting the strength.
Part of what makes atropine work well as a managed treatment is that the strength is adjustable. We may open at a lower concentration and change course depending on how the prescription behaves over the following months. It is not a prescribe-and-forget drop; it is a plan our optometric team revisits at every follow-up, tracking both the pace of progression and how comfortably your child tolerates the drop.
A pattern many Paoli parents recognize is that they were nearsighted as children too, and now they are watching the same thing unfold in their own kids. Family history is one of the strongest predictors of childhood myopia, and parents who wore glasses early are often the most motivated to do things differently for the next generation. Our West Chester office is a short drive away, and a family history of myopia is one of the most common reasons families seek us out.
Myopia tends to run in families. A child with one nearsighted parent has a higher likelihood of becoming myopic, and that likelihood rises further when both parents are nearsighted. Genetics influences how the eye grows and how prone it is to elongating during childhood. It does not seal a child's fate, but it does raise the odds and often the pace, which is why family history is a signal to watch a child's eyes closely from an early age.
Inherited tendency is only part of the story. The same near-work habits and limited outdoor time that influence any child's eyes can amplify a genetic predisposition. A child who inherits a higher baseline risk and also spends long hours on close-up tasks with little time outdoors may progress faster than genetics alone would predict. This is encouraging in a way, because while we cannot change a child's genes, we can influence the environmental factors and add medical treatment.
When myopia runs in the family, we encourage earlier and more attentive monitoring. Establishing a baseline prescription and tracking it lets us catch progression as soon as it accelerates, rather than after a large jump. For families where both parents needed glasses young, this watchfulness can make a real difference in starting a control plan at the right moment instead of playing catch-up.
Genetic risk does not change which tools we use, but it can change how proactively we use them. The options include MiSight 1 day contact lenses, FDA-approved to slow progression in children around ages 8 to 12, and low-dose atropine drops, commonly 0.01% to 0.05% and used off-label. Dr. Mudgil, a board-certified ophthalmologist with Johns Hopkins/Wilmer fellowship training, and our optometrist tailor the approach to the child. Acting matters because higher myopia is associated with greater lifetime risk of retinal detachment, glaucoma, and myopic maculopathy, and predisposed children can reach those higher levels if progression goes unchecked.
MiSight 1 day lenses and low-dose atropine drops are both proven, evidence-based ways to slow how quickly a child's nearsightedness advances. Neither cures myopia, and neither works the same in every child, so the right choice comes down to your child rather than a rigid protocol. Together we consider age and maturity, the current prescription and how fast it is moving, comfort with a contact lens, the degree of astigmatism, daily activities, and your family's preferences.
As a general guide, MiSight suits an older, contact-lens-ready child who is comfortable wearing a lens during the day, while low-dose atropine suits a younger child, a child not yet ready for lenses, or a family that prefers a simple nightly drop with glasses by day. Some children start with one method and switch as they grow, and in select cases the two are used together. Whichever we choose, myopia control is a managed plan: we measure the prescription, and where helpful the length of the eye, at regular visits and adjust over time. Results vary from child to child, and we aim for the best outcome for yours.
The best time to begin myopia control is early in the progression, while the eye is still growing and more future change can still be prevented. In practice that is often the first time a child needs distance glasses, or the first time a prescription jumps between yearly exams. Myopia most often appears between about ages 8 and 12, though it can begin earlier, and a Paoli child with nearsighted parents or a fast-changing prescription deserves a closer look sooner rather than later. No referral is needed to schedule an evaluation.
Most nearsighted children are candidates for some form of myopia control. The clearest signs that it is time to ask us include a prescription that rises at every visit, squinting or sitting close to the board or the television, frequent headaches or eye strain, and a family history of high myopia. Only a full evaluation can reveal which option fits, and part of our job is to tell you plainly whether myopia control is likely to help your child and which approach makes the most sense.
A myopia control evaluation is a thorough pediatric eye exam, not a quick screening. We measure your child's vision and full prescription, often with dilating drops for accuracy, check eye alignment and overall eye health, and record baseline measurements so we can follow progression precisely over time. Then we sit down with you and your child, explain the findings in plain language, and lay out the choices, including what each treatment involves day to day, what it can and cannot do, and the follow-up schedule. If a contact lens is the plan, we fit it and teach your child how to handle it. Expect the visit to run a little longer than a comprehensive eye exam, especially when drops are used.
Myopia management works best as a long-term relationship, and at Mudgil Eye Associates your child has an unusually complete team. Dr. Reetu R. Julakanti, our residency-trained pediatric optometrist, leads the day-to-day myopia control program for Paoli families, fitting MiSight lenses, prescribing and adjusting low-dose atropine, and following each child's progress across the years of treatment. Optometrists are the foundation of children's vision care, and Dr. Julakanti's focused pediatric training is exactly what a growing, shifting prescription calls for.
Alongside her is Dr. A. Vijay Mudgil, a board-certified, fellowship-trained pediatric ophthalmologist who completed his pediatric ophthalmology and strabismus fellowship at the Wilmer Eye Institute at Johns Hopkins and has cared for Chester County families for more than 20 years. He has been named a Main Line Today Top Doctor since 2009. Having an optometrist and a fellowship-trained pediatric ophthalmologist in the same practice means that if your child ever needs more than myopia control, from a tricky prescription to eye misalignment or a medical concern, that expertise is already on the team, with no new referral and no starting over.
Learn more about our pediatric eye care for children of all ages, or explore our full myopia management program for Chester County families.
Yes. Dr. Reetu Julakanti, our pediatric optometrist, fits FDA-approved MiSight 1 day contact lenses for children in the Paoli area. MiSight is a soft daily-disposable lens worn during the day that corrects vision and is proven to slow the progression of myopia in children.
Both are proven, evidence-based ways to slow how fast a child's nearsightedness progresses. MiSight suits an older child ready to handle a daily contact lens; low-dose atropine, a simple nightly eye drop, suits younger children or those not ready for contacts. Dr. Julakanti helps you choose and adjusts the plan over time.
Myopia control combines proven treatments, MiSight 1 day contact lenses and low-dose atropine, with lifestyle steps like more time outdoors. Paoli-area families see Dr. Julakanti, who builds a plan for each child and monitors progress at regular visits. Slowing progression matters because higher myopia raises the lifetime risk of eye problems later in life.
Myopia control is most effective when it begins early, while the eye is still growing and the greatest share of future change can still be prevented. Many Paoli children start between roughly ages 6 and 12, often at the first sign a prescription is rising, though there is no single correct age. A strong family history of nearsightedness is a good reason to look sooner. Because the goal is to limit change still to come, an earlier start generally leads to a lower final prescription, so an evaluation now usually beats waiting.
No. Myopia control neither cures nearsightedness nor reverses the prescription your child already has. What it does is slow how fast the myopia progresses during the growing years, so your child finishes less nearsighted than they otherwise would. Glasses or contacts will still be needed for clear sight, and results vary from child to child.
Neither is right for every child; the best fit depends on yours. MiSight 1 day lenses suit an older, contact-lens-ready child who is comfortable wearing a lens during the day. Low-dose atropine, a simple nightly drop worn with daytime glasses, suits younger children or those not yet ready for contacts. Both are evidence-based and proven to slow progression, and Dr. Julakanti helps you choose based on age, prescription, comfort with lenses, and lifestyle.
For most children it slows the rate of progression in a meaningful way, though it does not stop it completely or reverse existing nearsightedness. In its multi-year clinical study, MiSight was associated with roughly a 59 percent reduction in the rate of progression over three years, and low-dose atropine has slowed progression across multiple studies. These are clinical-study findings; each child's benefit varies, which is why we monitor and adjust at regular visits.
It helps as a supporting habit. Daylight time outdoors is associated with a lower chance of developing myopia and, in some studies, slower progression, with about two hours a day a commonly cited target. It is not a guarantee and does not replace treatment once a child is progressing, but it is a healthy, inexpensive habit we encourage alongside any lens or drop.
Yes. Active Paoli kids generally do well with myopia control. MiSight 1 day lenses are worn during the day and correct distance vision while they are worn, which many children prefer for sports, and each lens is discarded at night. Low-dose atropine is a bedtime drop, so it never interferes with daytime play; the child simply wears their usual glasses or sports eyewear. We are happy to talk through protective eyewear for your child's sport. Results vary from child to child.
It generally continues through the growing years, until the eyes stop changing and the prescription holds steady, often in the mid-to-late teens or early adulthood. Any wind-down is planned with us rather than done abruptly, and we time it to how your child's eyes are behaving. Regular follow-up visits stay part of the plan throughout.
You do not need a referral to schedule a myopia evaluation. Coverage for myopia control varies by plan, and some services or materials may not be covered by medical insurance, so our team reviews the details with you before treatment begins. Call our West Chester office at (610) 429-3004 and we will help you understand the options.
Most Paoli families are seen within one to two weeks for an initial myopia evaluation. Call 610-429-3004 or schedule online, and we will help you get ahead of your child's nearsightedness.